Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurological disorders
Pharma
Servier revenue growth hits 16% as group eyes €10B 2030 goal
As oncology serves as Servier’s main growth engine, the firm also aims to establish a “leading neurology franchise” modeled on its oncology strategy.
Angus Liu
Jan 27, 2026 10:55am
After Avadel setback, Lundbeck signals future M&A rigor
Jan 22, 2026 11:13am
Neurocrine's Ingrezza misses in cerebral palsy trial
Dec 23, 2025 10:20am
What's on neurologists' minds? Not drug names, survey shows
Jul 18, 2025 10:10am
BMS' schizophrenia drug stumbles in blow to blockbuster plan
Apr 23, 2025 10:35am
Neurology patients call out pharma for inadequate investment
Nov 19, 2024 11:20am
